Anshu Giri

Oncology | Otolaryngology
333 Cottman Avenue
Philadelphia, PA 19111

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Off-Target-Based Tumor Fraction Estimation from Targeted Sequencing Shows Concordance with Orthogonal Methods Across Advanced Solid Tumors.

Off-Target-Based Tumor Fraction Estimation from Targeted Sequencing Shows Concordance with Orthogonal Methods Across Advanced Solid Tumors.

Journal: International journal of molecular sciences
Published: May 24, 2026

Phase I study of oral azacitidine plus salvage chemotherapy in relapsed/refractory diffuse large B-cell lymphoma.

Phase I study of oral azacitidine plus salvage chemotherapy in relapsed/refractory diffuse large B-cell lymphoma.

Journal: Annals of hematology
Published: January 09, 2026

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.

Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 28, 2023

Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma.

Pembrolizumab as monotherapy in locally advanced cutaneous squamous cell carcinoma.

Journal: Expert review of anticancer therapy
Published: September 15, 2022

Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.

Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study.

Journal: American journal of hematology
Published: June 05, 2022

Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.

Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.

Journal: Head & neck
Published: August 18, 2020

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.

Journal: Blood advances
Published: August 27, 2019

Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.

Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge.

Journal: Cancers of the head & neck
Published: August 12, 2019

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.

Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.

Journal: Cancer
Published: March 07, 2019

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer.

Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer.

Journal: Reviews on recent clinical trials
Published: January 22, 2016

New Oral Anticoagulants and Their Reversal.

New Oral Anticoagulants and Their Reversal.

Journal: Current drug safety
Published: August 24, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026